Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism
- PMID: 17005710
- PMCID: PMC1861478
- DOI: 10.1136/hrt.2006.100628
Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism
Abstract
Background: There are limited systematic data on the incidence, clinical characteristics and outcomes of congestive heart failure (CHF) in patients with hyperthyroidism. The aim of this study was to investigate the incidence, clinical characteristics and outcome of CHF as the initial presentation in patients with primary hyperthyroidism.
Methods: The prevalence, clinical characteristics and outcome of CHF was studied in 591 consecutive patients (mean (SD) age 45 (1) years, 140 men) who presented with primary hyperthyroidism.
Results: CHF was the presenting condition in 34 patients (5.8%) with hyperthyroidism. The presence of atrial fibrillation at presentation (OR 37.4, 95% CI 9.72 to 144.0, p<0.001) was an independent predictor for the occurrence of CHF. Of the 34 patients with CHF, 16 (47%) had systolic left ventricular dysfunction with left ventricular ejection fraction (LVEF)<50%. They were predominantly male (OR 26.6, 95% CI 2.6 to 272.5, p = 0.006) and had a lower serum thyroxine level (OR 0.93, 95% CI 0.87 to 0.99, p = 0.044) than patients with preserved left ventricular systolic function. In these patients, LVEF (55 (4)% vs 30 (2)%, p<0.001) and New York Heart Association functional class (1.2 (0.1) vs 2.5 (0.2), p<0.001) improved significantly 3 months after achieving euthyroid status. Systolic left ventricular dysfunction (mean (SD) LVEF 38 (4)%) persisted on long-term follow-up in five
Patients: no clinical parameter could be identified to predict the occurrence of this persistent cardiomyopathy (p>0.05).
Conclusion: CHF was the initial clinical presentation in approximately 6% of patients with hyperthyroidism, and half of them had left ventricular systolic dysfunction. Symptoms of CHF subsided and LVEF improved after treatment for hyperthyroidism. Nonetheless, one-third of these patients developed persistent dilated cardiomyopathy.
Conflict of interest statement
Competing interests: None.
Similar articles
-
Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists. Data from the Italian Network on Congestive Heart Failure.Ital Heart J. 2002 Nov;3(11):656-64. Ital Heart J. 2002. PMID: 12506524
-
[Comparative study on characteristics of congestive heart failure patients with preserved versus abnormal left ventricular systolic function and evaluation effects of therapy].Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006 Apr;18(4):210-5. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006. PMID: 16647010 Chinese.
-
Heart failure in patients with preserved and deteriorated left ventricular ejection fraction.Heart. 2005 Apr;91(4):489-94. doi: 10.1136/hrt.2003.031922. Heart. 2005. PMID: 15772209 Free PMC article.
-
Hyperthyroidism: a "curable" cause of congestive heart failure--three case reports and a review of the literature.Congest Heart Fail. 2003 Jan-Feb;9(1):40-6. doi: 10.1111/j.1527-5299.2003.01124.x. Congest Heart Fail. 2003. PMID: 12556677 Review.
-
Severe reversible dilated cardiomyopathy and hyperthyroidism: case report and review of the literature.Endocr Pract. 2003 Mar-Apr;9(2):140-6. doi: 10.4158/EP.9.2.140. Endocr Pract. 2003. PMID: 12917077 Review.
Cited by
-
Thyrotoxicosis induced cardiogenic shock rescued by extracorporeal membrane oxygenation.J Geriatr Cardiol. 2018 Feb;15(2):203-204. doi: 10.11909/j.issn.1671-5411.2018.02.003. J Geriatr Cardiol. 2018. PMID: 29662515 Free PMC article. No abstract available.
-
Cardiac hypertrophy and thyroid hormone signaling.Heart Fail Rev. 2010 Mar;15(2):125-32. doi: 10.1007/s10741-008-9125-7. Epub 2009 Jan 6. Heart Fail Rev. 2010. PMID: 19125327 Free PMC article. Review.
-
Recovery following Thyroxine Treatment Withdrawal, but Not Propylthiouracil, Averts In Vivo and Ex Vivo Thyroxine-Provoked Cardiac Complications in Adult FVB/N Mice.Biomed Res Int. 2017;2017:6071031. doi: 10.1155/2017/6071031. Epub 2017 Jul 16. Biomed Res Int. 2017. PMID: 28791308 Free PMC article.
-
A young patient with Graves' disease presenting with a triad of heart failure, pancytopenia, and jaundice: A case report.Clin Case Rep. 2024 Apr 24;12(5):e8698. doi: 10.1002/ccr3.8698. eCollection 2024 May. Clin Case Rep. 2024. PMID: 38681046 Free PMC article.
-
Hyperthyroidism.Lancet. 2016 Aug 27;388(10047):906-918. doi: 10.1016/S0140-6736(16)00278-6. Epub 2016 Mar 30. Lancet. 2016. PMID: 27038492 Free PMC article. Review.
References
-
- Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001344501–509. - PubMed
-
- Klein I. Thyroid hormone and the cardiovascular system. Am J Med 199088631–637. - PubMed
-
- Kahaly G J, Kampmann C, Mohr‐Kahaly S. Cardiovascular hemodynamics and exercise tolerance in thyroid disease. Thyroid 200212473–481. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical